Status:

COMPLETED

Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers

Lead Sponsor:

Meditrina Pharmaceuticals

Conditions:

Menstruation Disorders

Eligibility:

FEMALE

25-45 years

Phase:

PHASE2

Brief Summary

Aromatase inhibitors have been approved for use in postmenopausal women to treat and prevent breast cancer. They act by blocking the action of the enzyme, aromatase, that is necessary for the producti...

Eligibility Criteria

Inclusion

  • Between the ages of 25 and 45 and pre-menopausal;
  • Non-lactating and not pregnant
  • able to follow the schedule of procedures
  • able to freely provide informed consent
  • have clinically acceptable physical examination and safety laboratory studies

Exclusion

  • current use of any form of systemic contraceptive
  • have self-reported irregular menstrual cycles
  • intercurrent illness(es) detected on the screening physical
  • unwilling or unable to use barrier methods of contraception
  • have evidence of endometrial polyps or myomata on TVU/SIS that would interfere with endometrial thickness measurement
  • detection of ovarian cyst(s) during adnexal examination on screening TVU/SIS measuring greater than 5 cm
  • have history of, or current cancer, on any form exclusive of basal cell carcinoma
  • BMI \>= 35
  • history of alcohol or drug abuse in the past 5 years
  • unwilling or unable to undergo study procedures within the necessary time frames
  • history or current liver abnormalities as defined by ALT or AST \> 2X ULN
  • treated or untreated diabetes defined as fasting blood sugar \>= 126 mg/dL
  • untreated hypertension
  • impaired renal function by estimated creatinine clearance \< 80mL/min
  • have estradiol levels \< 20 pg/ml and FSH levels \> 40 mIU/mL or
  • have a history of adverse reaction any aromatase inhibitor

Key Trial Info

Start Date :

March 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2007

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT00467493

Start Date

March 1 2007

End Date

September 1 2007

Last Update

June 3 2009

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Jasper Research Clinic

Kalamazoo, Michigan, United States, 49007

2

University Women's Care

Southfield, Michigan, United States, 48034